Webinar Recap: Advancements in Prostate Cancer Treatment
Last week, we hosted our annual webinar in collaboration with our dedicated users, focusing on optimizing SBRT and strategies to reduce side effects in prostate cancer treatment.
Highlights from the Webinar:
Prof. Arcangeli discussed the evolution of Prostate Cancer Radiotherapy and presented data from their latest study on single-fraction treatment for prostate cancer. Key takeaways:
- Efficiency: The median delivery time for the single-dose treatment was 4.3 minutes.
- Promising Outcomes: After 18 months of follow-up, there were very few grade 2 toxicity reports and zero grade 3, reflecting very promising patient outcomes.
The Edinburgh team shared insights from the recently published PACE-B trial, highlighting how five-fraction radiotherapy is becoming the new standard of care for prostate cancer treatment in the UK.
Prof. McLaren posed a critical question: “Why do we accept any toxicity?” This underscores the importance of striving for precision and safety in every aspect of treatment.
Joanne Mitchell, research radiographer from the Edinburgh team, expanded on the challenges posed by organ motion during radiotherapy:
- Dynamic Organs: Organs at risk are inherently dynamic due to the natural movement of a living, breathing body.
- Accurate Dose Delivery: Crucial for treatment efficacy and safety, as organ motion directly impacts these factors. She emphasized the responsibility of radiographers to deliver optimal treatment in every session.
Johannes Berhchold, Medical Physicist from SALK, shared clinical experiences from the Salzburg team, elaborating on the variability in prostate movement:
- Prostate Movement: Some prostates remain relatively stable, while others can move up to 1 cm within seconds.
- Raypilot System: This system can replace the need for fiducial markers, saving time during treatment.
This exchange of data and knowledge underscores the advancements in prostate cancer treatment and the shared commitment in the Raypilot Community to improving patient outcomes. We thank all participants and speakers for making this event a success.
See the full webinar, head over to our Media Page.